The T2R to eNOS pathway, specifically polymorphisms regulating T2R38 signaling, has been identified as clinically important in terms of increased susceptibility to upper respiratory infections and impaired patient outcomes in chronic rhinosinusitis (CRS) [35,36,37,38,40,41,42,115,116,117]. This evidence concerns the gene NOS3 and congenital rubella syndrome.